Literature DB >> 9694738

The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.

I H Still, J K Cowell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694738

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.

Authors:  Chitta S Kasyapa; Padmaja Kunapuli; Lesleyann Hawthorn; John K Cowell
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

2.  Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.

Authors:  Meir Wetzler; Michael T Brady; Erin Tracy; Zhang-Rong Li; Kathleen A Donohue; Kieran L O'Loughlin; Yijun Cheng; Amir Mortazavi; Amy A McDonald; Padmaja Kunapuli; Paul K Wallace; Maria R Baer; John K Cowell; Heinz Baumann
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

3.  Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.

Authors:  John K Cowell; Haiyan Qin; Tianxiang Hu; Qing Wu; Aaron Bhole; Mingqiang Ren
Journal:  Int J Cancer       Date:  2017-07-28       Impact factor: 7.396

4.  Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.

Authors:  MingQiang Ren; John K Cowell
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

5.  The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor.

Authors:  Iver Nordentoft; Poul Jørgensen
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.

Authors:  Ami Goradia; Michael Bayerl; Dennis Cornfield
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.

Authors:  Chitta Kasyapa; Ting-Lei Gu; Lalitha Nagarajan; Lalitha Natarajan; Roberto Polakiewicz; John K Cowell
Journal:  Proteomics       Date:  2009-08       Impact factor: 3.984

8.  Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.

Authors:  Mingqiang Ren; Xiurong Li; John K Cowell
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

9.  Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.

Authors:  Mingqiang Ren; Haiyan Qin; Qing Wu; Natasha M Savage; Tracy I George; John K Cowell
Journal:  Int J Cancer       Date:  2016-05-04       Impact factor: 7.396

10.  Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

Authors:  Dervla M Connaughton; Rufeng Dai; Danielle J Owen; Jonathan Marquez; Nina Mann; Adda L Graham-Paquin; Makiko Nakayama; Etienne Coyaud; Estelle M N Laurent; Jonathan R St-Germain; Lot Snijders Blok; Arianna Vino; Verena Klämbt; Konstantin Deutsch; Chen-Han Wilfred Wu; Caroline M Kolvenbach; Franziska Kause; Isabel Ottlewski; Ronen Schneider; Thomas M Kitzler; Amar J Majmundar; Florian Buerger; Ana C Onuchic-Whitford; Mao Youying; Amy Kolb; Daanya Salmanullah; Evan Chen; Amelie T van der Ven; Jia Rao; Hadas Ityel; Steve Seltzsam; Johanna M Rieke; Jing Chen; Asaf Vivante; Daw-Yang Hwang; Stefan Kohl; Gabriel C Dworschak; Tobias Hermle; Mariëlle Alders; Tobias Bartolomaeus; Stuart B Bauer; Michelle A Baum; Eva H Brilstra; Thomas D Challman; Jacob Zyskind; Carrie E Costin; Katrina M Dipple; Floor A Duijkers; Marcia Ferguson; David R Fitzpatrick; Roger Fick; Ian A Glass; Peter J Hulick; Antonie D Kline; Ilona Krey; Selvin Kumar; Weining Lu; Elysa J Marco; Ingrid M Wentzensen; Heather C Mefford; Konrad Platzer; Inna S Povolotskaya; Juliann M Savatt; Natalia V Shcherbakova; Prabha Senguttuvan; Audrey E Squire; Deborah R Stein; Isabelle Thiffault; Victoria Y Voinova; Michael J G Somers; Michael A Ferguson; Avram Z Traum; Ghaleb H Daouk; Ankana Daga; Nancy M Rodig; Paulien A Terhal; Ellen van Binsbergen; Loai A Eid; Velibor Tasic; Hila Milo Rasouly; Tze Y Lim; Dina F Ahram; Ali G Gharavi; Heiko M Reutter; Heidi L Rehm; Daniel G MacArthur; Monkol Lek; Kristen M Laricchia; Richard P Lifton; Hong Xu; Shrikant M Mane; Simone Sanna-Cherchi; Andrew D Sharrocks; Brian Raught; Simon E Fisher; Maxime Bouchard; Mustafa K Khokha; Shirlee Shril; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2020-09-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.